Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000168406 | SCV000219100 | pathogenic | Charcot-Marie-Tooth disease, type 2 | 2019-12-19 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine with histidine at codon 329 of the AARS protein (p.Arg329His). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and histidine. This variant is not present in population databases (ExAC no frequency). This variant has been observed to segregate with Charcot-Marie-Tooth disease in several families (PMID: 20045102, 22009580). ClinVar contains an entry for this variant (Variation ID: 8466). Experimental studies have shown that this missense change severely reduces enzyme activity of alanyl-tRNA synthetase (PMID: 22009580). For these reasons, this variant has been classified as Pathogenic. |
Lupski Lab, |
RCV000008987 | SCV000292343 | pathogenic | Charcot-Marie-Tooth disease, type 2N | 2015-08-18 | criteria provided, single submitter | research | This variant has been previously reported as disease-causing and was found in a proband and his father with axonal neuropathy |
Molecular Genetics Laboratory, |
RCV000192253 | SCV001156510 | pathogenic | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
Clinical Genetics Karolinska University Hospital, |
RCV001269580 | SCV001449668 | likely pathogenic | not provided | 2017-02-21 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000008987 | SCV000029201 | pathogenic | Charcot-Marie-Tooth disease, type 2N | 2012-01-01 | no assertion criteria provided | literature only | |
Gene |
RCV000192253 | SCV000239901 | pathogenic | Charcot-Marie-Tooth disease | 2015-04-30 | no assertion criteria provided | literature only |